| 英文别名 |
5-Fluoro-2-1-benzoxaborol-1-3H--ol;Tavaborole;AN-2690;5-fluoro-1-hydroxy-3H-2,1-benzoxaborole;5-Fluorobenzo[c][1,2]oxaborol-1(3H)-ol;AN 2690;1,3-dihydro-5-fluoro-1-hydroxy-2,1-benzoxaborole;2,1-Benzoxaborole,5-fluoro-1,3-dihydro-1-hydroxy;5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole;5-fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol;5-fluoro-3H-benzo[c][1,2]oxaborol-1-ol;onychomycosis;Tavaborole (USAN);UNII-K124A4EUQ3;AN-269;Tavaborole(AN-2690);AN-2690(Tavaborole);5-Fluoro-1-hydroxyl-1,3-dihydrobenzo[c][1,2]oxaborole;Kerydin;AN2690;2,1-Benzoxaborole, 5-fluoro-1,3-dihydro-1-hydroxy-;K124A4EUQ3;5-fluoro-2,1-benzoxaborol-1(3H)-ol;C7H6BFO2;5-Fluoro-3H-benzo[c][1,2)oxaborol-1-ol;Tavaborol;TAVABOROLE [INN];Tavaborole (AN-2690);EX-A1086;s4996;BRD-K76713213-001-02-1;Z1198279578;MB08883;TAVABOROLE [VANDF];tavaborolum;F11396;174671-46-6;DB-100333;MFCD10699483;HY-10980;CCG-266215;HSDB 8342;DB09041;Tavaborole [USAN];CHEBI:77942;NS00073562;BDBM50370987;T3775;DTXSID00169888;SCH-900340;DTXCID5092379;TAVABOROLE topical solution, 5%;Tavaborole [USAN:INN];SCHEMBL500016;CHEMBL443052;5-Fluoro-1-hydroxy-2,1-benzoxaborolane;TAVABOROLE [MI];DS-8392;p-fluorbenzoxaborole;BCP08730;D10169;AKOS006303927;TAVABOROLE [WHO-DD];EN300-125084;LFQDNHWZDQTITF-UHFFFAOYSA-N;SY038332;Tavaborole (>90%);Kerydin (TN);D01AE24;NCGC00264110-01;CS-1058;BRD-K76713213-001-01-3;TAVABOROLE [ORANGE BOOK];NCGC00264110-02;AC-30887;Q21011226 |